Brookfield Asset Management related stories
All articles and analysis
Side Letter: CVC's GP stake decision; PAG's growth close; Chinese double fundraiseCVC's willingness to consider a GP stake sale points to a strategy in rude health, despite recent controversies. Plus: Asia giant PAG has closed its growth fund and the Chinese firm which hired a former Eaton boss is gearing up to raise two funds. Here's today's brief, for our valued subscribers only.
Brookfield: Fundraising 'stronger than ever'Investor interest for all funds is 'stronger than we’ve ever seen', said chief executive Bruce Flatt on Thursday's Q1 earnings call, 'and we expect these funds to be larger than their predecessors'.
New secondaries players seek a slice of the actionM&A advisory businesses and mega-managers are storming a flourishing secondaries industry but are there enough opportunities to go round?
Side Letter: Ares buys into secondaries, EQT's diversity targetsPop quiz: What's the private markets strategy so attractive it's got Ares, Brookfield and TPG buying in? Plus, EQT has found its diverse hiring targets may have been a little too ambitious, while US teachers' pensions stand their ground amid a report into PE performance. Here's today's brief, for our valued subscribers only.
Secondaries growth leads to hiring spreeThe swift growth of the secondaries market means it is a struggle to find people with the right skills and the pivot towards GP-led deals has added to this.
Side Letter: Carried interest under fire, Dyal's credit conundrumA group of Democrats is pushing for carried interest reform in the US. Plus: Why not all of Dyal's portfolio GPs might be happy about its Owl Rock tie-up; and how NAV facilities transitioned from niche to mainstream. Here's today's brief, for our valued subscribers only.
Side Letter: Why ESG-linked credit lines aren't for everyoneWe hope you had an enjoyable Presidents Day and Lunar New Year long weekend. It's Fund Finance week here at PEI, and first under the microscope is whether ESG-linked credit lines are right for every firm. Plus: EQT's fund performance and Brookfield's fundraising super-cycle. Here's today's brief, for our valued subscribers only.
Pent-up demand points to big 2021 for secondariesDemand among buyers and LPs’ desire to manage their portfolios in the wake of covid-19 point to healthy transaction secondaries volumes in the year ahead.
Side Letter: Brookfield mega impact plan, Manulife mission, carry tax debate to reigniteApologies for stating the obvious, but covid-19's impact on the industry will be multi-faceted and cannot be overstated. One effect is the catalysis of thinking around impact investing (see Brookfield's predictions and our special report below). Another is the hit to public finances and the need to raise tax from somewhere: strap in for another round of the carried-interest-as-capital-gain debate. Here's today's brief, for our valued subscribers only.
Brookfield expects impact strategy to grow to $100bnThe firm's Global Transition Fund will invest in assets that will move the economy towards net-zero, including renewables, industrial businesses and infrastructure.